Eudragit® L100/N-trimethylchitosan chloride microspheres for oral insulin delivery

Molecules

Volumn 18, Issue 6, 2013, Pages 6734-6747

  Marais, Etienne ^a   Hamman, Josias ^a   Du Plessis, Lissinda ^a   Lemmer, Righard ^a   Steenekamp, Jan ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Eudragit L100; Insulin; Microspheres; N trimethylchitosan chloride; Oral peptide delivery; Paracellular transport

Indexed keywords

CHITOSAN; DRUG CARRIER; INSULIN; METHYLMETHACRYLATE METHACRYLIC ACID COPOLYMER; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; MICROSPHERE; N TRIMETHYL CHITOSAN CHLORIDE; N-TRIMETHYL CHITOSAN CHLORIDE; POLYMETHACRYLIC ACID DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; INTESTINE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PERMEABILITY; RAT; SYNTHESIS; MEDICINAL CHEMISTRY;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; INSULIN; INTESTINES; MALE; MICROSPHERES; PARTICLE SIZE; PERMEABILITY; POLYMETHACRYLIC ACIDS; RATS;

EID: 84879610766     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18066734     Document Type: Article

References (26)

1. Pauletti, G.M.; Gangwar, S.; Knipp, G.T.; Nerurkar, M.M.; Okumu, F.W.; Tamura, K.; Siahaan, T.J.; Borchardt, R.T. Structural requirements for intestinal absorption of peptide drugs. J. Controlled Release 1996, 41, 3-17.
2. Hamman, J.H.; Enslin, G.M.; Kotzé, A.F. Oral delivery of peptide drugs: barriers and developments. Biodrugs 2005, 19, 165-177.
3. Morishita, M.; Peppas, N.A. Is the oral route possible for peptide and protein drug delivery. Drug Discovery Today 2006, 11, 905-910.
4. Daugherty, A.L.; Mrsny, R.J. Transcellular uptake mechanisms of the intestinal epithelial barrier: part one. Pharm. Sci. Technol. Today 1999, 2, 144-151.
5. Park, K.; Kwon, I.C.; Park, P. Oral protein delivery: Current status and future prospect. React. Funct. Polym. 2010, 71, 280-287.
6. Ziv, E.; Lior, O.; Kidron, M. Absorption of protein via the intestinal wall. Biochem. Pharmacol. 1987, 36, 1035-1039.
7. Hosny, E.A.; Al-Shora, H.; Elmazar, M.M.A. Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: Effect on relative hypoglycemia of diabetic beagle dogs. Int. J. Pharm. 2002, 237, 71-76.
8. Nilkumhang, S.; Basit, A.W. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles. Int. J. Pharm. 2009, 377, 135-141.
9. Singh, M.N.; Hemant, K.S.Y.; Ram, M.; Shivakumar, H.G. Microencapsulation: a promising technique for controlled drug delivery. Res. Pharm. Sci. 2010, 5, 65-77.
10. Salamat-Miller, N.; Johnston, T.P. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. Int. J. Pharm. 2005, 294, 201-216.
11. Van Der Merwe, S.M.; Verhoef, J.C.; Verheijden, J.H.M.; Kotzé, A.F.; Junginger, H.E. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur. J. Pharm. Biopharm. 2004, 58, 225-235.
12. Thanou, M.; Verhoef, J.C.; Junginger, H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliver. Rev. 2001, 52, 117-126.
13. Thanou, M.; Verhoef, J.C.; Junginger, H.E. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliver. Rev. 2001, 50, S91-S101.
14. Kotzé, A.F.; Lueßen, H.L.; De Boer, A.G.; Verhoef, J.C.; Junginger, H.E. Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur. J. Pharm. Sci. 1998, 7, 145-151.
15. Kotzé, A.F.; Lueßen, H.L.; De Leeuw, B.J.; De Boer, A.G.; Verhoef, J.C.; Junginger, H.E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride in the permeability of intestinal epithelial cells (Caco-2). J. Control. Release 1998, 51, 35-46.
16. Thanou, M.M.; Verhoef, J.C.; Romeijn, S.G.; Nagelkerke, J.F.; Merkus, F.W.H.M.; Junginger, H.E. Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on Caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. Int. J. Pharm. 1999, 185, 73-82.
17. Snyman, D.; Hamman, J.H.; Kotzé. 2003. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. Drug Dev. Ind. Pharm. 2003, 29, 61-69.
18. Kotzé, A.F.; Thanou, M.M.; Lueen, H.L.; de Leeuw, B.J.; de Boer, A.G.; Verhoef, J.C.; Junginger, H.E. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J. Pharm. Sci. 1999, 88, 253-257.
19. Hamman, J.H.; Schultz, C.M.; Kotzé, A.F. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev. Ind. Pharm. 2003, 2, 161-172.
20. Sieval, A.B.; Thanou, M.; Kotzé, A.F.; Verhoef, J.C.; Brussee, J.; Junginger, H.E. Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohyd. Polym. 1998, 36, 157-165.
21. Watts, P.J.; Davies, M.C.; Mella, C.D. Microencapsulation using emulsification/solvent evaporation: An overview of techniques and applications. Crit. Rev. Ther. Drug Carrier Syst. 1990, 7, 235-259.
22. Rosca, I.D.; Watari, F.; Uo, M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J. Controlled Release 2004, 99, 271-280.
23. Muzzarelli, R.A.A. Colorimetric determination of chitosan. Anal. Biochem. 1998, 260, 255-257.
24. Martin, A.N.; Bustamante, P.; Chun, A.H.C. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences, 4th ed.; Lippincott Williams & Wilkins: Baltimore, MD, USA, 1993; p. 622.
25. Moore, J.W.; Flanner, H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 20, 64-74.
26. Palumbo, P.; Picchini, U.; Beck, B.; Van Gelder, J.; Delbar, N.; Degaetano, A. A general approach to the apparent permeability index. J. Pharmacokinet. Phar. 2008, 35, 235-248.